NASHVILLE, Tenn., July 27 /PRNewswire-FirstCall/ -- HCA (NYSE: HCA) today
announced results for its second quarter ended June 30, 2005. Net income for
the second quarter of 2005 was $405 million, or $0.90 per diluted share,
compared to $352 million, or $0.72 per diluted share, in the previous year's
second quarter. The Company's results for the second quarter include the
following:
- favorable tax settlement related to the Company's divestiture of
certain non-core business units in 1998 and 2001 of $48 million, or
$0.11 per diluted share;
- recognition of a previously deferred gain on the Company's sale of
certain medical office buildings (the MedCap properties) of $29 million
pretax, or $0.04 per diluted share; and
- additional depreciation expense of $30 million, or $0.04 per diluted
share, to correct accumulated depreciation and assure a consistent
application of the Company's accounting policy relative to certain
short-lived medical equipment.
Also, the Company recognized a reduction in its estimated professional
liability insurance reserves of $36 million pretax, or $0.05 per diluted
share, during the second quarter of 2005. Results for the second quarter of
2004 included a reduction in estimated professional liability reserves of
$59 million pretax, or $0.07 per diluted share. The adjustments to insurance
reserves reduce "other operating expenses" in the Company's consolidated
income statement.
Same facility admissions in the second quarter of 2005 decreased
0.3 percent and same facility equivalent admissions, which take into account
outpatient volume, increased 1.2 percent compared to the second quarter of
2004.
Same facility revenues rose 4.3 percent to $6.0 billion in the second
quarter of 2005 and same facility revenue per equivalent admission increased
3.1 percent compared to the prior year's second quarter. Adjusting for
discounts provided to uninsured patients of $183 million, same facility
revenues increased 7.5 percent and same facility revenue per equivalent
admission increased 6.2 percent in the second quarter of 2005 compared to the
second quarter of 2004. The Company also provided $275 million in charity
care in the second quarter of 2005 compared to $232 million in last year's
second quarter.
"Although the second quarter of 2005 results include the previously
mentioned items that affected several lines of our income statement, I believe
the results reflect a solid quarter with soft inpatient volume in some
markets, exceptional expense management, reasonable pricing growth and a
slight increase in bad debt expense," stated Jack O. Bovender, HCA's Chairman
and CEO.
The provision for doubtful accounts in the second quarter of 2005 was
$541 million, or 8.9 percent of revenues, compared to $661 million, or
11.3 percent of revenues, in the second quarter of 2004. Adjusting for the
effect of the uninsured discounts provided to the uninsured during the
quarter, the provision for doubtful accounts for the second quarter of 2005
would be $725 million, or 11.6 percent of revenues. The Company's uninsured
discount policy lowers revenues and the provision for doubtful accounts by
generally corresponding amounts. Uninsured patient admissions increased
5.1 percent in the second quarter of 2005 compared to the prior year period.
Same facility emergency room visits increased 3.4 percent in the second
quarter of 2005, compared to the same period of 2004. The same facility
outpatient surgeries increase of 1.2 percent was comprised of hospital based
outpatient surgical procedures which increased 1.0 percent and free-standing
outpatient surgical procedures which increased 1.7 percent, on a same facility
basis.
Revenues for the six months ended June 30, 2005 were $12.3 billion
compared to $11.8 billion in the same period of 2004. Net income totaled
$819 million, or $1.84 per diluted share, for the six months ended June 30,
2005 compared to $697 million, or $1.41 per diluted share, for the six months
ended June 30, 2004.
Cash Flow and Balance Sheet
HCA's cash flow from operations increased 11.9 percent to $763 million in
the second quarter of 2005 compared to $682 million in the second quarter of
2004.
As of June 30, 2005, the Company's balance sheet reflected total debt of
$9.4 billion, stockholders' equity (including common and minority equity) of
$6.9 billion and total assets of $21.7 billion. HCA's ratio of debt to debt
plus common and minority equity was 57.5 percent at June 30, 2005, compared to
61.7 percent at March 31, 2005 and 66.9 percent at December 31, 2004.
The Company had 452.0 million common shares outstanding at June 30, 2005,
compared to 441.2 million shares at March 31, 2005 and 422.6 million shares at
December 31, 2004.
Status of Asset Sales
A definitive agreement was signed with LifePoint Hospitals, Inc. for their
purchase of five hospitals located in Virginia and West Virginia for
$285 million, plus other adjustments and working capital valued at
approximately $45 million at March 31, 2005. A definitive agreement was also
signed with Capella Healthcare, a newly formed company headed by former
executives of Province Healthcare, for their purchase of five hospitals
located in Tennessee, Oklahoma, Louisiana and Washington for approximately
$260 million, inclusive of working capital. The divestitures are subject to
customary regulatory approvals and are expected to be completed in the fourth
quarter of 2005.
Earnings Guidance for 2005
With today's announcement, the Company is reaffirming its earnings
guidance for 2005 of $3.05 to $3.20 per diluted share, excluding gains on
sales of assets, impairments and tax settlements.
Facilities at Quarter End
At June 30, 2005, the Company operated 190 hospitals and 92 freestanding
surgery centers (including seven hospitals and eight freestanding surgery
centers operated through equity method joint ventures) located in 23 states,
London, England and Geneva, Switzerland compared to 190 hospitals and
91 freestanding surgery centers (including seven hospitals and
nine freestanding surgery centers operated through equity method joint
ventures) at June 30, 2004.
Earnings Conference Call
HCA will host a conference call for investors to discuss second quarter
results at 8:30 a.m. Central Daylight Time today. All interested investors
are invited to access a live audio broadcast of the call via webcast. The
broadcast also will be available on a replay basis beginning this afternoon
and through the next year. The webcast can be accessed via the following
link: http://phx.corporate-ir.net/phoenix.zhtml?p=irol-
eventDetails&c=63489&eventID=1098761 or on the Investor Relations page at
http://www.hcahealthcare.com.
CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS
This press release contains forward-looking statements based on current
management expectations. Those forward-looking statements include all
statements regarding our estimated results of operations for future periods
and all statements other than those made solely with respect to historical
fact. Numerous risks, uncertainties and other factors may cause actual results
to differ materially from those expressed in any forward-looking statements.
These factors include, but are not limited to, (i) increases in the amount and
risk of collectability of uninsured accounts and deductibles and co-pay
amounts for insured accounts, (ii) the ability to achieve operating and
financial targets, achieve expected levels of patient volumes and control the
costs of providing services, (iii) the highly competitive nature of the health
care business, (iv) the efforts of insurers, health care providers and others
to contain health care costs, (v) possible changes in the Medicare, Medicaid
and other state programs that may impact reimbursements to health care
providers and insurers, (vi) the ability to attract and retain qualified
management and other personnel, including affiliated physicians, nurses and
medical support personnel, (vii) potential liabilities and other claims that
may be asserted against the Company, (viii) fluctuations in the market value
of the Company's common stock, (ix) the impact of the Company's charity care
and uninsured discounting policy changes, (x) changes in accounting practices,
(xi) changes in general economic conditions, (xii) the ability to consummate
the divestitures of the ten hospitals on the terms set forth in the definitive
agreements (xiii) future divestitures which may result in charges, (xiv)
changes in revenue mix and the ability to enter into and renew managed care
provider arrangements on acceptable terms, (xv) the availability and terms of
capital to fund the expansion of the Company's business, (xvi) changes in
business strategy or development plans, (xvii) delays in receiving payments
for services provided, (xviii) the possible enactment of Federal or state
health care reform, (xix) the outcome of pending and any future tax audits,
appeals and litigation associated with the Company's tax positions, (xx) the
outcome of the Company's continuing efforts to monitor, maintain and comply
with appropriate laws, regulations, policies and procedures and the Company's
corporate integrity agreement with the government, (xxi) changes in Federal,
state or local regulations affecting the health care industry, (xxii) the
ability to develop and implement the payroll and human resources information
systems within the expected time and cost projections and, upon
implementation, to realize the expected benefits and efficiencies, (xxiii)
maintaining the increased quarterly cash dividend rate for the entire fiscal
year, and (xxiv) other risk factors detailed in the Company's filings with the
SEC. Many of the factors that will determine the Company's future results are
beyond the ability of the Company to control or predict. In light of the
significant uncertainties inherent in the forward-looking statements contained
herein, readers should not place undue reliance on forward-looking statements,
which reflect management's views only as of the date hereof. The Company
undertakes no obligation to revise or update any forward-looking statements,
or to make any other forward-looking statements, whether as a result of new
information, future events or otherwise.
All references to "Company" and "HCA" as used throughout this document
refer to HCA Inc. and its affiliates.
HCA Inc.
Consolidated Income Statements
Second Quarter
(Dollars in millions, except per share amounts)
2005 2004
Amount Ratio Amount Ratio
Revenues $6,070 100.0 % $5,833 100.0 %
Salaries and benefits 2,463 40.6 2,334 40.0
Supplies 1,042 17.2 967 16.6
Other operating expenses 981 16.2 891 15.3
Provision for doubtful accounts 541 8.9 661 11.3
Gains on investments (22) (0.4) (18) (0.3)
Equity in earnings of affiliates (53) (0.9) (53) (0.9)
Depreciation and amortization 364 6.0 315 5.4
Interest expense 165 2.7 136 2.3
Gains on sales of facilities (29) (0.5) - -
5,452 89.8 5,233 89.7
Income before minority interests and
income taxes 618 10.2 600 10.3
Minority interests in earnings of
consolidated entities 49 0.8 35 0.6
Income before income taxes 569 9.4 565 9.7
Provision for income taxes 164 2.7 213 3.7
Net income $405 6.7 $352 6.0
Diluted earnings per share $0.90 $0.72
Shares used in computing diluted
earnings per share (000) 451,731 490,261
Consolidated Income Statements
For the Six Months Ended June 30, 2005 and 2004
(Dollars in millions, except per share amounts)
2005 2004
Amount Ratio Amount Ratio
Revenues $12,252 100.0 % $11,770 100.0 %
Salaries and benefits 4,906 40.0 4,667 39.7
Supplies 2,093 17.1 1,947 16.5
Other operating expenses 1,953 15.9 1,842 15.6
Provision for doubtful accounts 1,115 9.1 1,355 11.5
Gains on investments (31) (0.2) (28) (0.2)
Equity in earnings of affiliates (106) (0.9) (99) (0.8)
Depreciation and amortization 701 5.7 618 5.2
Interest expense 329 2.7 271 2.3
Gains on sales of facilities (29) (0.2) - -
10,931 89.2 10,573 89.8
Income before minority interests and
income taxes 1,321 10.8 1,197 10.2
Minority interests in earnings of
consolidated entities 89 0.7 73 0.7
Income before income taxes 1,232 10.1 1,124 9.5
Provision for income taxes 413 3.4 427 3.6
Net income $819 6.7 $697 5.9
Diluted earnings per share $1.84 $1.41
Shares used in computing diluted
earnings per share (000) 443,739 493,941
HCA Inc.
Supplemental Operating Results Summary
(Dollars in millions, except per share amounts)
For the Six Months
Ended June 30,
Second Quarter 2005
2005 2004 2005 2004
Revenues $6,070 $5,833 $12,252 $11,770
Net income $405 $352 $819 $697
Gains on sales of facilities (net of
tax) (18) - (18) -
Tax settlement (48) - (48) -
Net income, excluding gains on sales
of facilities and tax settlement(a) 339 352 753 697
Depreciation and amortization 364 315 701 618
Interest expense 165 136 329 271
Minority interests in earnings of
consolidated entities 49 35 89 73
Provision for income taxes 201 213 450 427
Adjusted EBITDA (a) $1,118 $1,051 $2,322 $2,086
Diluted earnings per share:
Net income $0.90 $0.72 $1.84 $1.41
Gains on sales of facilities (0.04) - (0.04) -
Tax settlement (0.11) - (0.11) -
Net income, excluding gains on
sales of facilities and tax
settlement (a) $0.75 $0.72 $1.69 $1.41
Shares used in computing diluted
earnings per share (000) 451,731 490,261 443,739 493,941
(a) Net income, excluding gains on sales of facilities and tax settlement
and adjusted EBITDA are non-GAAP financial measures. The Company
believes that net income excluding, gains on sales of facilities and
tax settlement and adjusted EBITDA are important measures that
supplement discussions and analysis of the Company's results of
operations. The Company believes that it is useful to investors to
provide disclosures of its results of operations on the same basis as
that used by management. HCA's management relies upon net income,
excluding gains on sales of facilities and tax settlement and adjusted
EBITDA as the primary measures to review and assess operating
performance of its hospital facilities and their management teams.
Management and investors review both the Company's overall performance
(including net income, excluding gains on sales of facilities and tax
settlement, GAAP net income and GAAP EPS) and operating performance of
the Company's health care facilities (adjusted EBITDA). Adjusted
EBITDA and the adjusted EBITDA margin (adjusted EBITDA divided by
revenues) are utilized by management and investors to compare the
Company's current operating results with the corresponding periods
during the previous year and to compare the Company's operating
results with other companies in the health care industry. The Company
recorded gains on sales of facilities and a tax settlement during the
second quarter of 2005. It is reasonable to expect that gains on
sales of facilities and tax settlements will occur in future periods,
but the amounts recognized for these items can vary significantly from
quarter to quarter, do not directly relate to the ongoing operations
of the Company's health care facilities and complicate quarterly
comparisons of the Company's results of operations and operations
comparisons with other health care companies.
Net income, excluding gains on sales of facilities and tax settlement
and adjusted EBITDA are not measures of financial performance under
accounting principles generally accepted in the United States, and
should not be considered as alternatives to net income as a measure of
operating performance or to cash flows from operating, investing and
financing activities as a measure of liquidity. Because net income,
excluding gains on sales of facilities and tax settlement and adjusted
EBITDA are not measurements determined in accordance with generally
accepted accounting principles and are susceptible to varying
calculations, net income, excluding gains on sales of facilities and
tax settlement and adjusted EBITDA, as presented, may not be
comparable to other similarly titled measures presented by other
companies.
HCA Inc.
Supplemental Non-GAAP Disclosures
Operating Measures Adjusted For the Impact of Discounts for the Uninsured
Second Quarter 2005
(Dollars in millions, except revenue per equivalent admission)
Reported Uninsured Non-GAAP GAAP % Non-GAAP %
GAAP Discount Adjusted of Adjusted
Amounts Adjustment(a) Amounts(b) Revenues Revenues
Reported: 2005 2004 2005
Revenues $6,070 $184 $6,254 100.0% 100.0% 100.0%
Salaries and
benefits 2,463 - 2,463 40.6% 40.0% 39.4%
Supplies 1,042 - 1,042 17.2% 16.6% 16.7%
Other operating
expenses 981 - 981 16.2% 15.3% 15.5%
Provision for
doubtful
accounts 541 184 725 8.9% 11.3% 11.6%
Admissions 407,600 407,600
Equivalent
admissions 619,700 619,700
Revenue per
equivalent
admission $9,795 $10,092
% change from
prior year 2.6% 5.7%
Same Facility:
Revenues $6,010 $183 $6,193
Admissions 406,300 406,300
Equivalent
admissions 613,900 613,900
Revenue per
equivalent
admission $9,790 $10,087
% change from
prior year 3.1% 6.2%
(a) Represents the impact of the discounts for the uninsured for the
period. On January 1, 2005, HCA modified its policies to
provide discounts to uninsured patients who do not qualify for
Medicaid or charity care. These discounts are similar to
those provided to many local managed care plans. In implementing
the discount policy HCA first attempts to qualify
uninsured patients for Medicaid, other Federal or state assistance
or charity care. If an uninsured patient does not qualify
for these programs, the uninsured discount is applied.
(b) Revenues, the provision for doubtful accounts, certain operating
expense categories as a percentage of revenues and revenue
per equivalent admission have been adjusted to exclude the
discounts under HCA's uninsured discount policy (non-GAAP
financial measures). The Company believes that these non-GAAP
financial measures are useful to investors to provide dis-
closures of its results of operations on the same basis as that
used by management. Management uses this information to
compare revenues, the provision for doubtful accounts, certain
operating expense categories as a percentage of revenues and
revenue per equivalent admission for periods prior and subsequent
to the January 1, 2005 implementation of the uninsured
discount policy. Management finds this information to be useful
to enable the evaluation of revenue and certain expense
category trends that are influenced by patient volumes and are
generally analyzed as a percentage of net revenues. These
non-GAAP financial measures should not be considered an
alternative to GAAP financial measures. The Company believes
this supplemental information provides it and the users of its
financial statements with useful information for period-to-period
comparisons. Investors are encouraged to use GAAP measures when
evaluating the Company's overall financial performance.
HCA Inc.
Supplemental Non-GAAP Disclosures
Operating Measures Adjusted For the Impact of Discounts for the Uninsured
Six Months Ended June 30, 2005
(Dollars in millions, except revenue per equivalent admission)
Reported Uninsured Non-GAAP GAAP % Non-GAAP %
GAAP Discount Adjusted of Adjusted
Amounts Adjustment(a) Amounts(b) Revenues Revenues
Reported: 2005 2004 2005
Revenues $12,252 $293 $12,545 100.0% 100.0% 100.0%
Salaries and
benefits 4,906 - 4,906 40.0% 39.7% 39.1%
Supplies 2,093 - 2,093 17.1% 16.5% 16.7%
Other operating
expenses 1,953 - 1,953 15.9% 15.6% 15.5%
Provision for
doubtful
accounts 1,115 293 1,408 9.1% 11.5% 11.2%
Admissions 840,200 840,200
Equivalent
admissions 1,256,100 1,256,100
Revenue per
equivalent
admission $9,754 $9,987
% change from
prior year 2.4% 4.9%
Same Facility:
Revenues $12,143 $291 $12,434
Admissions 837,500 837,500
Equivalent
admissions 1,248,800 1,248,800
Revenue per
equivalent
admission $9,724 $9,957
% change from
prior year 2.7% 5.2%
(a) Represents the impact of the discounts for the uninsured for the
period. On January 1, 2005, HCA modified its policies to
provide discounts to uninsured patients who do not qualify for
Medicaid or charity care. These discounts are similar to
those provided to many local managed care plans. In implementing
the discount policy HCA first attempts to qualify
uninsured patients for Medicaid, other Federal or state assistance
or charity care. If an uninsured patient does not qualify
for these programs, the uninsured discount is applied.
(b) Revenues, the provision for doubtful accounts, certain operating
expense categories as a percentage of revenues and revenue
per equivalent admission have been adjusted to exclude the
discounts under HCA's uninsured discount policy (non-GAAP
financial measures). The Company believes that these non-GAAP
financial measures are useful to investors to provide dis-
closures of its results of operations on the same basis as that
used by management. Management uses this information to
compare revenues, the provision for doubtful accounts, certain
operating expense categories as a percentage of revenues and
revenue per equivalent admission for periods prior and subsequent
to the January 1, 2005 implementation of the uninsured
discount policy. Management finds this information to be useful to
enable the evaluation of revenue and certain expense
category trends that are influenced by patient volumes and are
generally analyzed as a percentage of net revenues. These
non-GAAP financial measures should not be considered an alternative
to GAAP financial measures. The Company believes
this supplemental information provides it and the users of its
financial statements with useful information for period-to-period
comparisons. Investors are encouraged to use GAAP measures when
evaluating the Company's overall financial performance.
HCA Inc.
Condensed Consolidated Balance Sheets
(Dollars in millions)
June 30, March 31, December 31,
ASSETS 2005 2005 2004
Current assets:
Cash and cash equivalents $463 $144 $129
Accounts receivable, less allowance
for doubtful accounts 3,214 3,254 3,083
Inventories 580 577 577
Deferred income taxes 464 458 467
Other 370 484 427
5,091 4,917 4,683
Property and equipment, at cost 20,344 20,216 19,970
Accumulated depreciation (9,160) (8,888) (8,574)
11,184 11,328 11,396
Investments of insurance subsidiary 1,997 1,953 2,047
Investments in and advances to affiliates 556 611 486
Goodwill 2,622 2,579 2,540
Deferred loan costs 92 96 99
Other 176 205 214
$21,718 $21,689 $21,465
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable $832 $842 $855
Accrued salaries 578 581 579
Other accrued expenses 1,255 1,298 1,254
Long-term debt due within one year 560 486 486
3,225 3,207 3,174
Long-term debt 8,800 9,372 10,044
Professional liability risks 1,303 1,326 1,283
Deferred taxes and other liabilities 1,472 1,664 1,748
Minority interests in equity of
consolidated entities 801 789 809
Stockholders' equity 6,117 5,331 4,407
$21,718 $21,689 $21,465
Current ratio 1.58 1.53 1.48
Ratio of debt to debt plus common and
minority equity 57.5% 61.7% 66.9%
Shares outstanding (thousands) 451,963 441,167 422,642
HCA Inc.
Consolidated Statements of Cash Flows
For the Six Months Ended June 30, 2005 and 2004
(Dollars in millions)
2005 2004
Cash flows from operating activities:
Net income $819 $697
Adjustments to reconcile net income
to net cash provided by operating activities:
Provision for doubtful accounts 1,115 1,355
Depreciation and amortization 701 618
Income taxes 222 254
Change in operating assets and liabilities (1,341) (1,533)
Other 70 63
Net cash provided by operating
activities 1,586 1,454
Cash flows from investing activities:
Purchase of property and equipment (625) (787)
Acquisition of hospitals and health
care entities (84) (30)
Disposal of hospitals and health
care entities 36 28
Change in investments (110) (71)
Other 25 1
Net cash used in investing activities (758) (859)
Cash flows from financing activities:
Issuance of long-term debt - 501
Net change in revolving bank credit facility (700) (160)
Repayment of long-term debt (480) (383)
Repurchase of common stock - (592)
Issuance of common stock 922 127
Payment of cash dividends (123) (72)
Other (113) (11)
Net cash used in financing activities (494) (590)
Change in cash and cash equivalents 334 5
Cash and cash equivalents at beginning of period 129 115
Cash and cash equivalents at end of period $463 $120
Interest payments $308 $258
Income tax payments, net of refunds $191 $173
HCA Inc.
Operating Statistics
For the Six Months
Second Quarter Ended June 30, 2005
2005 2004 2005 2004
Consolidated Hospitals:
Number of Hospitals 183 183 183 183
Weighted Average Licensed
Beds 41,948 41,962 41,903 41,948
Licensed Beds at End of
Period 42,013 41,930 42,013 41,930
Reported:
Admissions 407,600 410,500 840,200 840,800
% Change -0.7% -0.1%
Equivalent Admissions 619,700 610,800 1,256,100 1,236,000
% Change 1.5% 1.6%
Revenue per Equivalent
Admission $9,795 $9,550 $9,754 $9,523
% Change 2.6% 2.4%
Inpatient Revenue per
Admission $9,163 $8,807 $9,115 $8,748
% Change 4.0% 4.2%
Patient Days 2,009,100 2,033,400 4,168,300 4,207,000
Equivalent Patient Days 3,055,400 3,026,100 6,231,600 6,184,300
Inpatient Surgery Cases 136,400 135,500 271,900 270,900
% Change 0.6% 0.3%
Outpatient Surgery Cases 216,200 213,000 427,200 420,500
% Change 1.5% 1.6%
Emergency Room Visits 1,345,600 1,309,600 2,737,400 2,606,500
% Change 2.7% 5.0%
Outpatient Revenues as a
Percentage of
Patient Revenues 37.5% 37.1% 36.5% 36.6%
Average Length of Stay 4.9 5.0 5.0 5.0
Occupancy 52.6% 53.3% 55.0% 55.1%
Equivalent Occupancy 79.9% 79.3% 82.2% 81.0%
Same Facility:
Admissions 406,300 407,600 837,500 834,800
% Change -0.3% 0.3%
Equivalent Admissions 613,900 606,900 1,248,800 1,228,000
% Change 1.2% 1.7%
Revenue per Equivalent
Admission $9,790 $9,494 $9,724 $9,467
% Change 3.1% 2.7%
Inpatient Revenue per
Admission $9,211 $8,787 $9,116 $8,722
% Change 4.8% 4.5%
Inpatient Surgery Cases 136,500 134,300 271,300 269,000
% Change 1.7% 0.8%
Outpatient Surgery Cases 212,400 209,800 420,100 414,200
% Change 1.2% 1.4%
Emergency Room Visits 1,338,900 1,294,300 2,724,200 2,578,200
% Change 3.4% 5.7%
Number of Consolidated and
Non-Consolidated (50/50 Equity
Joint Ventures) Hospitals:
Consolidated 183 183 183 183
Non-Consolidated (50/50
Equity Joint Ventures) 7 7 7 7
Total Number of Hospitals 190 190 190 190
SOURCE HCA
CONTACT: Investor, Mark Kimbrough, +1-615-344-2688,
or Media, Jeff Prescott, +1-615-344-5708,
both of HCA
;){kind=link}